![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|18|15|2207-2213
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.18, Iss.15, 2012-05, pp. : 2207-2213
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The vulnerable atherosclerotic plaque
Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Biomarkers Associated with Vulnerable Atheromatous Plaque
Current Medicinal Chemistry, Vol. 19, Iss. 16, 2012-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Matrix Metalloproteinases and Vulnerable Atheromatous Plaque
Current Topics in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Contrast-enhanced Ultrasound for Liver Imaging: Recent Advances
Current Pharmaceutical Design, Vol. 18, Iss. 15, 2012-05 ,pp. :